Cn /En

News Center

——

Company news

Industry news

InnoModels Biotechnology: What are the features and advantages of the ADCC platform?

Author:

InnoModels

Release time:

2024-06-07

In today's era of rapid development of biotechnology, InnoModels' ADCC platform is leading a new era of drug development and clinical treatment with its unique features and advantages. The platform not only has a diversified experimental service system, but also focuses on simulating the in vivo environment to provide researchers with accurate and reliable data support. In the following, we will introduce the features of InnoModels' ADCC platform in detail.
First of all, the ADCC platform of InnoModels Biotechnology has a diversified experimental service system. It supports a variety of tumor cell and immune cell combination experiments, whether it is tumor cell lines, primary tumor cells or genetically engineered cell lines, the platform can provide the appropriate experimental conditions and technical support. This diversified experimental system allows researchers to select the most suitable cell types according to specific research needs, thus more accurately simulating biological processes in vivo.
Secondly, the platform focuses on simulating the in vivo environment to more realistically reflect the actual situation of the ADCC process. In terms of experimental design, the InnoModels Biotechnology ADCC platform utilizes advanced cell culture technology and flow cytometry. These technologies are able to monitor and record the changes of cells in real-time during the experiment, effectively differentiate effective target cells, count and calculate the proportion of apoptotic cells. In this way, researchers can gain a deeper understanding of the mechanism of the ADCC process, providing powerful support for drug development and clinical treatment.

In addition, the InnoModels ADCC platform has highly consistent primary cells. Utilizing the digestion products of the PDX model, the platform is able to obtain primary cells that are highly consistent with patients. Such cells have complex cellular subpopulations and biological characteristics that allow drug action and response to be more closely aligned with the clinical situation. Therefore, the platform is able to provide more accurate and reliable data support in drug screening and clinical treatment.
In addition to the above features, the InnoModels Biotechnology ADCC platform also has the advantage of drug response and clinical relevance. The platform is not only applicable to the screening of subject drugs and models, but also capable of predicting the clinical efficacy of drugs. By comparing the subject drug with counterpart drugs (e.g., drugs with similar mechanism of action or standardized therapeutic drugs), the platform can predict the clinical value of the drug, providing a powerful reference for drug development and clinical application.
In addition, the InnoModels Biotechnology ADCC platform has multi-dimensional applications. In addition to drug screening, the platform can also play a role in multiple dimensions. For example, by comparing the efficiency of different cancer type models, the indication of a drug can be determined; by comparing the difference in gene characteristics between sensitive and resistant models, biomarkers that can predict drug efficacy can be searched. This multi-dimensional application makes the platform more widely applicable and can meet the needs of researchers in different fields.
In summary, with its diversified experimental service system, simulation of in vivo environment, highly consistent primary cells, and the advantages of drug efficacy response and clinical relevance, the InnoModels ADCC platform provides powerful support for drug discovery and clinical treatment. With the continuous development of biotechnology, it is believed that the InnoModels Biotechnology ADCC platform will play an even more important role in the future and promote greater breakthroughs and progress in the field of biotechnology.

InnoModels Biotechnology: What are the features of the ELISpot platform?

InnoModels Biotechnology: What are the features of the CDX platform?

InnoModels Biotechnology: What are the features of the ELISpot platform?

InnoModels Biotechnology: What are the features of the CDX platform?

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL: +86 15711355061
E-mail: xuyl@imodels.tech
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing

COOKIES

Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy

COOKIES

required

These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.

analyze

These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.

Feature

These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.

advertise

These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.

InnoModels Biotechnology (Beijing) Co., Ltd

SEO

Business License